2018 – Page 10 – MJZanon IP Attorney – Expert Patent & Trademark Lawyer in Brazil

Adocia Informs about a Civil Action filed by Eli Lilly

Thursday, October 11, 2018 Angiotensin II receptor blockers no prescription viagra may also be connected with birth defects. This concoction

AbbVie and Sandoz resolve Humira biosimilar patent disputes

DrugName : adalimumab AbbVie, a research-based global biopharmaceutical company, announced a global resolution of all intellectual property-related litigation with Sandoz

WIPO and IFPMA Launch New Online Patent-Search Resource to Help Health Agencies Procure Medicines

Geneva, September 25, 2018 PR/2018/821 Released jointly by WIPO and IFPMA WIPO and the research-based pharmaceutical industry today launched a

Could US Biosimilars Stakeholders Benefit from Certain Initiatives Similar to Those Offered in Emerging Markets?

Created Date: October 2018 DRFCode: GDHC2053EI Could US Biosimilars Stakeholders Benefit from Certain Initiatives Similar to Those Offered In Emerging

Rival companies to tap $20bn global market with biosimilars for Humira

Monday, October 15, 2018 This is perhaps viagra soft tablet the main reason why impotence erectile dysfunction is Kamagra Jelly.